Drug class
Equine-derived polyclonal antitoxin immunoglobulin; toxin-neutralising biologic
Mechanism of action
Contains antibodies that bind and neutralise circulating diphtheria toxin, preventing toxin from entering cells and inhibiting further tissue injury. It does not reverse toxin already internalised into cells.
General use cases
- Treatment of suspected or confirmed respiratory diphtheria as early as possible, together with appropriate antibiotics and supportive care; administration requires urgent public-health and specialist guidance
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
